New Market Research Report: Cavadis B.V. - Product Pipeline Analysis, 2013 Update
Cavadis B.V. (Cavadis) is a biomedical company. The company provides products and services in the field of cardiovascular risk assessment. Its product includes Cavadis. Cavadis's product contains a series of novel biomarkers in various phases of development. The company uses individual markers and multi-marker panels to develop prognostic tests for cardiovascular indications such as myocardial infarction, stroke and peripheral artery disease. It collaborates with UMC Utrecht, Center for Translational Molecular Medicine and Athero-Express to provide access to biomarker discovery platform....
View full press release